Skip to main content
. 2020 Sep 9;7(1):70–84. doi: 10.1016/j.ijwd.2020.08.007

Table 4.

Drugs with anticholinergic effects (adapted from Duran et al., 2013).

Drug class Common examples
Anticholinergics Atropine
Scopolamine
Hyoscyamine
Belladona alkaloids
Antitussives Homatropine
Antihistamines Cyproheptadine
Promethazine
Diphenhydramine
Dexchorpheniramine
Hydroxyzine
Chlorpheniramine
Brompheniramine
Carbinoxamine
Pyrilamine
Loratadine
Cetirizine
Fexofenadine
Cimetidine
Ranitidine
Antipruritics Trimeprazine (alimemazine)
SSRI/SSNI antidepressants Venlafaxine*
Trazadone
Fluoxetine
Fluvoxamine
Paroxetine
Citalopram
Mirtazapine
Nefazodone
Tricyclic antidepressants Amitriptyline
Doxepin
Imipramine
Nortriptyline
Chlomipramine
Desipramine
Protriptyline
Trimipramine
Dosulepin
MAO inhibitor antidepressants Phenelzine
Anti-anxiety/insomnia Chlordiazepoxide
Clonazepam
Diazepam
Temazepam
Triazolam
Antipsychotics Chlozapine
Chlorpromazine
Fluphenazine
Thioridazine
Thiothixene
Trifluoperazine
Perphenazine
Quetiapine
Olanzapine
Risperidone
Ziprasidone
Haloperidol
Loxapine
Molindone
Promazine
Antiparkinsonians Benztropine
Trihexyphenidyl
Procyclidine
Amantadine
Bromocriptine
Entacapone
Anticonvulsants Carbamazepine
Oxcarbazepine
Bladder antispasmodics Oxybutynin
Tolterodine
Darifenacin
Propantheline
Emepronium
Flavoxate
Gastrointestinal relaxants Dicyclomine
Propantheline
Gastric motility stimulant Metoclopramide
Antiemetics/antivertigo Levomepromazine
Meclozine
Dimenhydrinate
Promethazine
Domperidone
Prochlorperazine
Muscle relaxants Orphenadrine
Tizanidine
Carisoprodol
Cyclobenzaprine
Methocarbamol
Baclofen
Inhalants/antibronchospastics Ipratropium

MOA = monoamine oxidase; SSRI = selective serotonin reuptake inhibitor; SSNI = serotonin–norepinephrine reuptake inhibitor.

Bold font: high-potency anticholinergic activity; normal font: low-potency anticholinergic activity.

*

Little to no anticholinergic effect.

Uncertain; high potency in some studies.